Evidence map›Paper›PMID 38700873›Full record

ArticleInvestigative ophthalmology & visual science2024

Sex Distributions in Non-ABCA4 Autosomal Macular Dystrophies.

Amit V Mishra, Sandra Vermeirsch, Siying Lin, Maria P Martin-Gutierrez, Mark Simcoe, Nikolas Pontikos, Elena Schiff, Thales A C de Guimarães, Pirro G Hysi, Michel Michaelides and 3 more

Abstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Amit V MishraGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Sandra VermeirschGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Siying LinGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Maria P Martin-GutierrezGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Mark SimcoeUCL Institute of Ophthalmology, University College London, London, United Kingdom.
Nikolas PontikosGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Elena SchiffGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Thales A C de GuimarãesGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Pirro G HysiSection of Ophthalmology, King's College London, St. Thomas' Hospital Campus, London, United Kingdom.
Michel MichaelidesGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Gavin ArnoGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Andrew R WebsterGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.
Omar A MahrooGenetics Service, Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Purpose: We sought to explore whether sex imbalances are discernible in several autosomally inherited macular dystrophies. Methods: We searched the electronic patient records of our large inherited retinal disease cohort, quantifying numbers of males and females with the more common (non-ABCA4) inherited macular dystrophies (associated with BEST1, EFEMP1, PROM1, PRPH2, RP1L1, and TIMP3). BEST1 cases were subdivided into typical autosomal dominant and recessive disease. For PRPH2, only patients with variants at codons 172 or 142 were included. Recessive PROM1 and recessive RP1L1 cases were excluded because these variants give a more widespread or peripheral degeneration. The proportion of females was calculated for each condition; two-tailed binomial testing was performed. Where a significant imbalance was found, previously published cohorts were also explored. Results: Of 325 patients included, numbers for BEST1, EFEMP1, PROM1, PRPH2, RP1L1, and TIMP3 were 152, 35, 30, 50, 14, and 44, respectively. For autosomal dominant Best disease (n = 115), there were fewer females (38%; 95% confidence interval [CI], 29-48%; P = 0.015). For EFEMP1-associated disease (n = 35), there were significantly more females (77%; 95% CI, 60%-90%; P = 0.0019). No significant imbalances were seen for the other genes. When pooling our cohort with previous large dominant Best disease cohorts, the proportion of females was 37% (95% CI, 31%-43%; P = 1.2 × 10-5). Pooling previously published EFEMP1-cases with ours yielded an overall female proportion of 62% (95% CI, 54%-69%; P = 0.0023). Conclusions: This exploratory study found significant sex imbalances in two autosomal macular dystrophies, suggesting that sex could be a modifier. Our findings invite replication in further cohorts and the investigation of potential mechanisms.

Indexed as

Macular DegenerationExtracellular Matrix ProteinsEye ProteinsFemaleHumansMalePeripherinsSex DistributionTissue Inhibitor of Metalloproteinase-3Extracellular Matrix ProteinsEye ProteinsPeripherinsPRPH2 protein, humanTissue Inhibitor of Metalloproteinase-3

Identifiers

PMID38700873
PMCPMC11077905

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.